Franziska Sophia Miegel

Dr. Franziska Sophia Miegel

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2022 in Psychiatric Quarterly
Verified
Journal Article
Closed access
PDF file
FMFranziska Sophia Miegel
Franziska Sophia Miegel
LBLara Bücker
Lara Bücker
SKSimone Kühn
Simone Kühn
FMFariba Mostajeran
Fariba Mostajeran
SMSteffen Moritz
Steffen Moritz
LJLena Jelinek
Lena Jelinek

1 July 2021 in Journal of Obsessive-Compulsive and Related Disorders
Verified
Journal Article
Closed access
FMFranziska Sophia Miegel
Franziska Sophia Miegel
SMSteffen Moritz
Steffen Moritz
BHBirgit Hottenrott
Birgit Hottenrott
CDCüneyt Demiralay
Cüneyt Demiralay
LJLena Jelinek
Lena Jelinek

1 February 2019 in Psychiatry Research
Verified
Journal Article
Closed access
FMFranziska Sophia Miegel
Franziska Sophia Miegel
LJLena Jelinek
Lena Jelinek
SMSteffen Moritz
Steffen Moritz

1 December 2020 in Personality and Individual Differences
Verified
Journal Article
Closed access
FMFranziska Sophia Miegel
Franziska Sophia Miegel
SMSteffen Moritz
Steffen Moritz
FWFrederike Wagener
Frederike Wagener
BCBarbara Cludius
Barbara Cludius
LJLena Jelinek
Lena Jelinek

21 September 2020 in Journal of Gambling Studies
Verified
Journal Article
Open access
PDF file
JGJosefine Gehlenborg
Josefine Gehlenborg
LBLara Bücker
Lara Bücker
MBMira Berthold
Mira Berthold
FMFranziska Sophia Miegel
Franziska Sophia Miegel
SMSteffen Moritz
Steffen Moritz
Approximately 90% of problem and pathological gamblers remain untreated. This treatment gap may be diminished by the implementation of low-threshold treatment programs. As cognitive distortions play a crucial role in the development and maintenance of gambling problems, interventions targeting gambling-related biases may be particularly effective. The aim of the present study was to examine the feasibility, acceptance, and safety of a novel metacognitive training for individuals with gambling problems (Gambling-MCT). Twenty-five participants were included in an uncontrolled pilot trial with two assessment points (intervention). The intervention comprised eight training modules targeting gambling-specific cognitive distortions. At baseline and post assessment, symptom severity, as measured with the PG-YBOCS, and gambling-related cognitive distortions, as measured with the GABS, were assessed. In addition, interim assessments measuring session-specific changes were conducted. Subjective appraisal was examined after each module and also post treatment. On average, participants took part in 4.16 (SD = 2.84) training sessions. Both intent-to-treat and per protocol analyses showed significant improvements on the PG-YBOCS and the GABS (dz = 0.37–1.37). After Bonferroni correction for multiple testing, linear mixed models for the analysis of session-specific changes showed no deterioration in participants’ mental state after any of the modules. Subjective appraisal of Gambling-MCT was good. The present pilot study provides first evidence for the feasibility, acceptance, and safety of Gambling-MCT. Recruitment of participants remains challenging, emphasizing the importance of overcoming patient-related treatment barriers. Future studies need to investigate the efficacy of Gambling-MCT in randomized controlled trials.

6 July 2020 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
FMFranziska Sophia Miegel
Franziska Sophia Miegel
CDCüneyt Demiralay
Cüneyt Demiralay
SMSteffen Moritz
Steffen Moritz
JWJanina Wirtz
Janina Wirtz
BHBirgit Hottenrott
Birgit Hottenrott
LJLena Jelinek
Lena Jelinek
Background: A high number of patients with obsessive-compulsive disorder (OCD) do not receive cognitive-behavioral therapy with exposure and response prevention, which is the most effective treatment for OCD. Therefore, Metacognitive Training for OCD (MCT-OCD) was developed, which is a structured group therapy aiming at the modification of dysfunctional (meta-)cognitive biases, beliefs and coping styles. It can be administered by less trained personnel, thus may reach a higher number of patients.An uncontrolled pilot study (MCT-OCD pilot version) provided first evidence that the training is highly accepted by patients; OC symptoms decreased with a high effect size (η2partial = 0.50). The aim of the present study is to address the shortcomings of the pilot study (e.g., no control group) and to assess the efficacy of the revised version of the MCT-OCD in the framework of a randomized controlled trial.Methods: Eighty patients with OCD will be recruited. After a blinded assessment at baseline (−t1), patients will be randomly assigned either to the intervention group (MCT-OCD;n = 40) or to a care as usual control group (n = 40). The MCT-OCD aims to enhance patients’ metacognitive competence in eight modules by addressing dysfunctional (meta-)cognitive biases and beliefs associated with OCD (e.g., intolerance of uncertainty). After 8 weeks, patients will be invited to a post assessment (t1), and then they will receive a follow-up online questionnaire 3 months following t1 (t2). The primary outcome is the Y-BOCS total score, and the secondary outcomes include the HDRS, OCI-R, OBQ-44, MCQ-30, WHOQOL-BREF, BDI-II, and subjective appraisal ratings of the MCT-OCD. We expect that OC symptoms will decrease more in the intervention group compared with the care as usual control group from –t1 to t1 and that treatment gains will be maintained until t2.Discussion: The planned study is the first to investigate the MCT-OCD, a promising new treatment, in a randomized controlled trial. The MCT-OCD may help to overcome existing treatment barriers for patients with OCD.Trial registration: German Registry for Clinical Studies (DRKS00013539), 22.02.2018.